Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance.

24-hour EEG antiseizure medication (ASM) classification generalized paroxysmal fast activity (GPFA) generalized polyspike train (GPT) idiopathic generalized epilepsy (IGE) prognosis prolonged ambulatory EEG (paEEG)

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 28 12 2021
accepted: 09 02 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 1 4 2022
Statut: epublish

Résumé

To investigate the electroclinical characteristics and the prognostic impact of generalized fast discharges in a large cohort of genetic generalized epilepsy (GGE) patients studied with 24-h prolonged ambulatory electroencephalography (paEEG). This retrospective multicenter cohort study included 202 GGE patients. The occurrence of generalized paroxysmal fast activity (GPFA) and generalized polyspike train (GPT) was reviewed. GGE patients were classified as having idiopathic generalized epilepsy (IGE) or another GGE syndrome (namely perioral myoclonia with absences, eyelid myoclonia with absences, epilepsy with myoclonic absences, generalized epilepsy with febrile seizures plus, or GGE without a specific epilepsy syndrome) according to recent classification proposals. GPFA/GPT was found in overall 25 (12.4%) patients, though it was significantly less frequent in IGE compared with other GGE syndromes (9.3 vs. 25%, We found that generalized fast discharges were more common than expected in GGE patients when considering the entire GGE spectrum. In addition, our study highlighted that GPFA/GPT could be found along the entire GGE continuum, though their occurrence was more common in less benign GGE syndromes. Finally, we confirmed that GPFA/GPT was associated with difficult-to-treat GGE, as evidenced by the multivariable analysis and the higher ASM load during history.

Identifiants

pubmed: 35356452
doi: 10.3389/fneur.2022.844674
pmc: PMC8960043
doi:

Types de publication

Journal Article

Langues

eng

Pagination

844674

Informations de copyright

Copyright © 2022 Cerulli Irelli, Barone, Mari, Morano, Orlando, Salamone, Marchi, Fanella, Fattouch, Placidi, Giallonardo, Izzi and Di Bonaventura.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Epilepsy Res Suppl. 1991;2:49-71
pubmed: 1662048
Epilepsia. 1998 Jun;39(6):660-3
pubmed: 9637609
Neurology. 2019 Jul 16;93(3):e215-e226
pubmed: 31227617
Epilepsia. 2005;46 Suppl 9:57-66
pubmed: 16302876
J Neurol Neurosurg Psychiatry. 1996 Nov;61(5):471-7
pubmed: 8937341
CNS Drugs. 2006;20(11):911-6
pubmed: 17044728
Epilepsia. 2010 Jun;51(6):1069-77
pubmed: 19889013
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1276-1285
pubmed: 31248935
J Clin Neurophysiol. 2021 May 1;38(3):208-212
pubmed: 31880591
Epilepsy Res. 2001 Sep;46(3):241-50
pubmed: 11518625
Ann Neurol. 2010 Jan;67(1):64-73
pubmed: 20186859
Seizure. 2014 Sep;23(8):607-15
pubmed: 24908140
Neurology. 2017 Sep 19;89(12):1210-1219
pubmed: 28842445
Epilepsia. 2011 Aug;52 Suppl 5:3-9
pubmed: 21790560
Clin Neurophysiol. 2016 Jan;127(1):214-220
pubmed: 26122071
Epilepsy Behav. 2017 Nov;76:101-104
pubmed: 28874317
J Neurophysiol. 1998 Sep;80(3):1495-513
pubmed: 9744954
Int J Neural Syst. 2013 Feb;23(1):1250030
pubmed: 23273126
J Clin Neurophysiol. 2020 Dec 8;:
pubmed: 33298682
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Int J Mol Sci. 2021 May 25;22(11):
pubmed: 34070602
Epilepsia. 2001 Mar;42(3):351-6
pubmed: 11442152
J Clin Neurophysiol. 2021 Jan 1;38(1):1-29
pubmed: 33475321
Epileptic Disord. 2001 Jan-Mar;3(1):23-7
pubmed: 11313219
Seizure. 2004 Jun;13(4):270-6
pubmed: 15121138
Neurophysiol Clin. 2002 Nov;32(5):287-96
pubmed: 12490326
Neurology. 2018 Nov 6;91(19):e1822-e1830
pubmed: 30315071
Epilepsia. 2022 Jan;63(1):150-161
pubmed: 34705264
Epilepsia. 2020 Nov;61(11):2452-2460
pubmed: 33345323
Seizure. 2022 Jan;94:52-56
pubmed: 34864252

Auteurs

Emanuele Cerulli Irelli (E)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Francesca Antonietta Barone (FA)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Luisa Mari (L)

Epilepsy Center, Neurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.

Alessandra Morano (A)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Biagio Orlando (B)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Enrico Michele Salamone (EM)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Angela Marchi (A)

Epilepsy Center, Neurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.

Martina Fanella (M)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Jinane Fattouch (J)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Fabio Placidi (F)

Epilepsy Center, Neurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.

Anna Teresa Giallonardo (AT)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Francesca Izzi (F)

Epilepsy Center, Neurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.

Carlo Di Bonaventura (C)

Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.

Classifications MeSH